Rare diseases
Investigational molecules
Locations
43 conditions with trials, the busiest first
37 trials across Europe, recruiting first
Study on the Safety of Vonafexor for Patients with Alport Syndrome at Risk of Progression
FranceStudy on SENS-401 to Prevent Hearing Loss Caused by Cisplatin in Adults with Cancer
FranceStudy on Long-Term Safety and Effects of SAR421869 for Patients with Usher Syndrome Type 1B
FranceStudy on Nimodipine for Hearing Preservation in Patients Undergoing Acoustic Schwannoma Surgery
GermanyStudy of AAVB-081 and Prednisolone for Patients with Usher Syndrome Type 1B Retinitis Pigmentosa
ItalyStudy on the Effects of Sodium Valproate for Hearing Preservation in Patients with Wolfram Syndrome
FranceStudy on R3R01 for Patients with Alport Syndrome and Primary Steroid-Resistant Focal Segmental Glomerulosclerosis
BelgiumStudy on the Safety of Lutetium (177Lu) Oxodotreotide, L-Lysine Hydrochloride, and L-Arginine Hydrochloride in Adolescents with Neuroendocrine Tumors and PPGLs
FranceStudy on the Effectiveness and Safety of AC102 Injection vs. Oral Prednisolone for Patients with Sudden Hearing Loss
AustriaStudy on ACOU085 to Prevent Hearing Loss in Testicular Cancer Patients Receiving Cisplatin
GermanyStudy on the Safety and Effects of Setanaxib for Patients with Alport Syndrome
AustriaStudy on SENS-501 for Children with Severe Hearing Loss Due to Otoferlin Gene Mutations
FranceThe therapies tested most often in Ear and labyrinth disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
